Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports

BACKGROUND: In metastatic colorectal cancer (mCRC), the anti-vascular endothelial growth factor drug bevacizumab (BVZ) plus chemotherapy significantly improves progression-free survival compared to chemotherapy (CT) alone. This benefit is not, however, observed in all patients. While increased chemo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Novillo, Apolonia, Gaibar, María, Romero-Lorca, Alicia, Gilsanz, María Fuencisla, Beltrán, Laura, Galán, Miguel, Antón, Beatriz, Malón, Diego, Moreno, Amalia, Fernández-Santander, Ana
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7201148/
https://ncbi.nlm.nih.gov/pubmed/32390708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i16.1979
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados